Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PCG vs GSK✓SelectedUSD · GSKPCG vs GSK performance historyLatest closeAs of+3.25%11/16
Stock and ETF performance explorer

PCG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-15.1%
GSK return
+9.7%
Excess return
-24.8%
Maximum drawdown
-37.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+3.2%-0.1%+3.3%+3.3%
7D+4.1%-1.3%+5.4%+4.4%
30D+4.5%+2.7%+1.8%+3.8%
3M-23.0%+2.7%-25.7%-23.6%
6M-14.6%+3.3%-17.9%-15.5%
YTD-14.0%+6.5%-20.5%-15.3%
All-15.1%+9.7%-24.8%-16.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling